Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Plos One
|
June 7, 2007
Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort
Marianne A B van der Sande, Steve Kaye, David J C Miles, et al.
The Lancet. Global Health
|
July 2, 2016
Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia
Ed Clarke, Yauba Saidu, Jane U Adetifa, et al.
The Lancet. Infectious Diseases
|
February 22, 2016
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study
Grant A Mackenzie, Philip C Hill, David J Jeffries, et al.
The Lancet. Infectious Diseases
|
July 19, 2021
Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance
, Grant A Mackenzie, Philip C Hill, et al.
The Lancet. Infectious Diseases
|
June 12, 2017
Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies
Grant A Mackenzie, Philip C Hill, Shah M Sahito, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Plos One
|
June 7, 2007
Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort
Marianne A B van der Sande, Steve Kaye, David J C Miles, et al.
The Lancet. Global Health
|
July 2, 2016
Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia
Ed Clarke, Yauba Saidu, Jane U Adetifa, et al.
The Lancet. Infectious Diseases
|
February 22, 2016
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study
Grant A Mackenzie, Philip C Hill, David J Jeffries, et al.
The Lancet. Infectious Diseases
|
July 19, 2021
Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance
, Grant A Mackenzie, Philip C Hill, et al.
The Lancet. Infectious Diseases
|
June 12, 2017
Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies
Grant A Mackenzie, Philip C Hill, Shah M Sahito, et al.
Page
of 3